BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 9453400)

  • 1. Red blood cell osmotic fragility in chronically hemodialyzed patients.
    Wu SG; Jeng FR; Wei SY; Su CZ; Chung TC; Chang WJ; Chang HW
    Nephron; 1998; 78(1):28-32. PubMed ID: 9453400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of relation between secondary hyperparathyroidism and red blood cell osmotic fragility in chronic renal failure.
    Docci D; Turci F; Baldrati L
    Nephron; 1985; 41(3):241-5. PubMed ID: 3840575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dialysis on erythrocyte membrane of chronically hemodialyzed patients.
    Ibrahim FF; Ghannam MM; Ali FM
    Ren Fail; 2002 Nov; 24(6):779-90. PubMed ID: 12472200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osmotic fragility of erythrocytes, cell deformability and secondary hyperparathyroidism in uremic patients on maintenance hemodialysis.
    Docci D; del Vecchio C; Salvi P; Turci F; Salvi G; Cenciotti L; Pretolani E
    Clin Nephrol; 1985 Feb; 23(2):68-73. PubMed ID: 3987101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of relation between serum parathyroid hormone levels and erythrocyte osmotic fragility in pediatric patients on peritoneal dialysis.
    Koşan C; Sever L; Arisoy N
    Ren Fail; 2004 Nov; 26(6):683-7. PubMed ID: 15600260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiological aspects of red blood cells in end-stage renal disease patients resistant to recombinant human erythropoietin therapy.
    Georgatzakou HT; Tzounakas VL; Kriebardis AG; Velentzas AD; Papageorgiou EG; Voulgaridou AI; Kokkalis AC; Antonelou MH; Papassideri IS
    Eur J Haematol; 2017 Jun; 98(6):590-600. PubMed ID: 28295628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of parathyroid hormone on osmotic fragility of human erythrocytes.
    Bogin E; Massry SG; Levi J; Djaldeti M; Bristol G; Smith J
    J Clin Invest; 1982 Apr; 69(4):1017-25. PubMed ID: 6281309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone effect on the fragility of human young and old red blood cells in uremia.
    Malachi T; Bogin E; Gafter U; Levi J
    Nephron; 1986; 42(1):52-7. PubMed ID: 3941750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of red blood cell osmotic fragility.
    Yamamoto A; Saito N; Yamauchi Y; Takeda M; Ueki S; Itoga M; Kojima K; Kayaba H
    J Lab Autom; 2014 Oct; 19(5):483-7. PubMed ID: 24751394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical changes associated with the osmotic fragility of young and mature erythrocytes caused by parathyroid hormone in relation to the uremic syndrome.
    Levi J; Malachi T; Djaldetti M; Bogin E
    Clin Biochem; 1987 Apr; 20(2):121-5. PubMed ID: 2955961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cell osmotic fragility in healthy loggerhead and green sea turtles.
    Radisic R; Owens SD; Manire CA; Montgomery N; Mader D; Zirkelbach B; Stacy NI
    J Vet Diagn Invest; 2020 Nov; 32(6):908-911. PubMed ID: 32996405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between serum carnitine levels and erythrocyte osmotic fragility in hemodialysis patients.
    Matsumura M; Hatakeyama S; Koni I; Mabuchi H; Muramoto H
    Nephron; 1996; 72(4):574-8. PubMed ID: 8730424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative injury to erythrocytes, cell rigidity and splenic hemolysis in hemodialyzed patients before and during erythropoietin treatment.
    Zachée P; Ferrant A; Daelemans R; Coolen L; Goossens W; Lins RL; Couttenye M; De Broe ME; Boogaerts MA
    Nephron; 1993; 65(2):288-93. PubMed ID: 8247195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red blood cell survival in long-term dialysis patients.
    Vos FE; Schollum JB; Coulter CV; Doyle TC; Duffull SB; Walker RJ
    Am J Kidney Dis; 2011 Oct; 58(4):591-8. PubMed ID: 21715072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte survival in chronic renal failure. Role of secondary hyperparathyroidism.
    Akmal M; Telfer N; Ansari AN; Massry SG
    J Clin Invest; 1985 Oct; 76(4):1695-8. PubMed ID: 4056047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective role of calcium ion against stress-induced osmotic fragility of red blood cells in patients with type 2 diabetes mellitus.
    Mostafavi E; Nakhjavani M; Ghazizadeh Z; Barakati H; Mirmiranpour H; Safari R
    Clin Hemorheol Microcirc; 2013 Jan; 53(3):239-45. PubMed ID: 22465964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Osmotic resistance in erythrocytes in patients with chronic renal insufficiency].
    Jakić M; Rupcić V; Stipanić S; Slanovic V
    Lijec Vjesn; 1991; 113(11-12):398-401. PubMed ID: 1669608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
    Olszewska M
    Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red blood cell deformability and secondary hyperparathyroidism in uremic patients on maintenance hemodialysis.
    Docci D; Turci F; Salvi P; Pretolani E
    Artif Organs; 1984 May; 8(2):141-4. PubMed ID: 6547327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative injury to erythrocytes, cell rigidity, and splenic hemolysis in hemodialyzed uremic patients.
    Rosenmund A; Binswanger U; Straub PW
    Ann Intern Med; 1975 Apr; 82(4):460-5. PubMed ID: 1119763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.